https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/LEQEMBI-Intravenous-Infusion-Lecanemab-Approved-for-the-Treatment-of-Alzheimer-s-Disease-in-Ja-44911748/?utm_source=telegram&utm_medium=social&utm_campaign=share